Young Gyoon Chang

Title: Young Gyoon Chang: Innovator in Antigen-Binding Molecules

Introduction

Young Gyoon Chang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antigen-binding molecules. With a total of 2 patents, his work is paving the way for advancements in medical treatments.

Latest Patents

Chang's latest patents focus on chimeric antigen receptors that bind to HLA-DR and CAR-T cells. These inventions relate to antigen-binding molecules that include specific heavy and light chain variable regions. The detailed sequences of these regions are crucial for the functionality of the T cell receptors (TCR) that he has developed. His innovative approach aims to enhance the efficacy of T cell therapies in treating various diseases.

Career Highlights

Young Gyoon Chang is currently associated with Eutilex Co., Ltd., where he continues to push the boundaries of research in immunotherapy. His expertise in antigen-binding molecules has positioned him as a key player in the biotechnology sector. His work is instrumental in the ongoing development of targeted therapies that could revolutionize cancer treatment.

Collaborations

Chang collaborates with notable colleagues, including Byoung S Kwon and Young Ho Kim. These partnerships enhance the research environment and foster innovation within their projects.

Conclusion

Young Gyoon Chang's contributions to the field of biotechnology through his patents and collaborations are noteworthy. His work on chimeric antigen receptors represents a significant step forward in medical science.